Evidence map›Paper›PMID 39038032›Full record

ArticlePLoS neglected tropical diseases2024

Antimicrobial activity of NK cells to Trypanosoma cruzi infected human primary Keratinocytes.

Keshia Kroh, Jessica Barton, Helena Fehling, Hanna Lotter, Beate Volkmer, Rüdiger Greinert, Mouna Mhamdi-Ghodbani, Andrea Vanegas Ramirez, Thomas Jacobs, Rosa Isela Gálvez

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Keshia KrohProtozoa Immunology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Jessica BartonProtozoa Immunology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Helena FehlingMolecular Infection Immunology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Hanna LotterMolecular Infection Immunology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Beate VolkmerSkin Cancer Center, Division of Molecular Cell Biology, Elbe Klinikum Buxtehude, Buxtehude, Germany.
Rüdiger GreinertSkin Cancer Center, Division of Molecular Cell Biology, Elbe Klinikum Buxtehude, Buxtehude, Germany.
Mouna Mhamdi-GhodbaniSkin Cancer Center, Division of Molecular Cell Biology, Elbe Klinikum Buxtehude, Buxtehude, Germany.
Andrea Vanegas RamirezDepartment of Dermatology, Bundeswehr Hospital Hamburg & Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Thomas JacobsProtozoa Immunology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Rosa Isela GálvezProtozoa Immunology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.ORCID 0000-0002-9320-2570

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infection with the protozoan parasite Trypanosoma cruzi is causative for Chagas disease, which is a highly neglected tropical disease prevalent in Latin America. Humans are primary infected through vectorial transmission by blood-sucking triatomine bugs. The parasite enters the human host through mucous membranes or small skin lesions. Since keratinocytes are the predominant cell type in the epidermis, they play a critical role in detecting disruptions in homeostasis and aiding in pathogen elimination by the immune system in the human skin as alternative antigen-presenting cells. Interestingly, keratinocytes also act as a reservoir for T. cruzi, as the skin has been identified as a major site of persistent infection in mice with chronic Chagas disease. Moreover, there are reports of the emergence of T. cruzi amastigote nests in the skin of immunocompromised individuals who are experiencing reactivation of Chagas disease. This observation implies that the skin may serve as a site for persistent parasite presence during chronic human infection too and underscores the significance of investigating the interactions between T. cruzi and skin cells. Consequently, the primary objective of this study was to establish and characterize the infection kinetics in human primary epidermal keratinocytes (hPEK). Our investigation focused on surface molecules that either facilitated or hindered the activation of natural killer (NK) cells, which play a crucial role in controlling the infection. To simulate the in vivo situation in humans, an autologous co-culture model was developed to examine the interactions between T. cruzi infected keratinocytes and NK cells. We evaluated the degranulation, cytokine production, and cytotoxicity of NK cells in response to the infected keratinocytes. We observed a strong activation of NK cells by infected keratinocytes, despite minimal alterations in the expression of activating or inhibitory ligands on NK cell receptors. However, stimulation with recombinant interferon-gamma (IFN-γ), a cytokine known to be present in significant quantities during chronic T. cruzi infections in the host, resulted in a substantial upregulation of these ligands on primary keratinocytes. Overall, our findings suggest the crucial role of NK cells in controlling acute T. cruzi infection in the upper layer of the skin and shed light on keratinocytes as potential initial targets of infection.

Indexed as

Chagas DiseaseKeratinocytesKiller Cells, NaturalTrypanosoma cruziAnimalsCells, CulturedCytokinesHumansCytokines

Identifiers

PMID39038032
PMCPMC11262665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.